Monitoring

  • Patients should be followed up clinically as needed for response to therapy and to rule out emerging neurologic deficits that may indicate an alternative underlying diagnosis.

  • Patients receiving botulinum toxin therapy are typically followed up every 3 months, while other patients with an established diagnosis can be followed up less frequently.

  • No ongoing laboratory testing, imaging, or physiologic testing is routinely indicated.

Use of this content is subject to our disclaimer